Skip to main content
. 2022 May 19;17(2):138–145. doi: 10.5114/pg.2022.116373

Table V.

Distribution of the pre-treatment histopathological findings

Variable Group 1 n (%) Group 2 n (%) Group 3 n (%) Group 4 n (%) P-value
H. pylori 50 (100) 50 (100) 50 (100) 50 (100)
Intestinal metaplasia 3 (6) 5 (10) 8 (16) 5 (10) 0.44
Atrophy 6 (12) 3 (6) 10 (20) 3 (6) 0.09
Dysplasia 0 (0) 0 (0) 1 (2) 0 (0) 0.39